Results 21 to 30 of about 512,141 (378)

Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer

open access: yesNature, 2018
Alterations in both cell metabolism and transcriptional programs are hallmarks of cancer that sustain rapid proliferation and metastasis1. However, the mechanisms that control the interaction between metabolic reprogramming and transcriptional regulation
Subhamoy Dasgupta   +14 more
semanticscholar   +1 more source

SRChing for the substrates of Src [PDF]

open access: yesOncogene, 2013
By the mid 1980's, it was clear that the transforming activity of oncogenic Src was linked to the activity of its tyrosine kinase domain and attention turned to identifying substrates, the putative next level of control in the pathway to transformation.
Scott A. Weed   +6 more
openaire   +2 more sources

Src Substrate Surprise [PDF]

open access: yesCancer Cell, 2009
In this issue of Cancer Cell, Lowy and colleagues show that the SH2 domain of tensin-3 is regulated by phosphorylation by Src and that this phosphorylation promotes the oncogenic function of tensin-3. Phosphorylation of the SH2 domain represents a novel mechanism for the regulation of SH2 ligand binding.
openaire   +3 more sources

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer [PDF]

open access: yes, 2017
SRC tyrosine kinase is frequently overexpressed and activated in late-stage, poor prognosis ovarian tumours, and preclinical studies have supported the use of targeted SRC inhibitors in the treatment of this disease.
El-Helali, Aya   +6 more
core   +2 more sources

SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis

open access: yesJournal of Biological Chemistry, 2018
When properly employed, targeted therapies are effective cancer treatments. However, the development of such therapies requires the identification of targetable drivers of cancer development and metastasis.
John M. Lamar   +7 more
semanticscholar   +1 more source

LAMININS IN COLORECTAL CANCER: EXPRESSION, FUNCTION, PROGNOSTIC POWER AND MOLECULAR MECHANISMS

open access: yesИсследования и практика в медицине, 2017
Extracellular matrix (ECM) proteins are a major component of the tumor stroma. Laminins emerge as one of the main families of ECM proteins with signaling properties.
S. A. Rodin, D. V. Maltseva
doaj   +1 more source

Short-range correlations in (e,e$'$p) and (e,e$'$pp) reactions on complex nuclei [PDF]

open access: yes, 1995
The influence of short-range correlations (SRC) on the triple-coincidence (e,e$'$pp) reactions is studied. The non-relativistic model uses a mean-field potential to account for the distortions that the escaping particles undergo. Apart from the SRC, that
Benhar   +24 more
core   +2 more sources

ESSENTIAL ROLE OF LYN IN FIBROSIS

open access: yesFrontiers in Physiology, 2016
Fibrotic disorders involve replacement of normal parenchyma with myofibroblasts, which deposit connective tissue, leading to obliteration of the function of the underlying organ.
Hung Pham   +10 more
doaj   +1 more source

SRC promotes lipogenesis: implications for obesity and breast cancer

open access: yesMolecular & Cellular Oncology, 2021
Remodeling of lipid metabolism has been implicated in cancers; however, it remains obscure how the lipid metabolic pathways are altered by oncogenic signaling to affect tumor development. We have recently shown that proto-oncogene tyrosine-protein kinase
Shu-Yong Lin, Sheng-Cai Lin
doaj   +1 more source

Opposing effects of inhibitors of Aurora-A and EGFR in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

open access: yesFrontiers in Oncology, 2015
Aurora-A kinase (AURKA) overexpression in numerous tumors induces aneuploidy, in part because of cytokinetic defects. Alisertib and other small-molecule inhibitors targeting AURKA are effective in some patients as monotherapies or combination therapies.
Anna S Nikonova   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy